Exthymic Corporation is developing a family of cell therapy devices and therapeutic assets to reduce the cost of and increase the access to curative engineered cell therapies like CAR-T cell therapy for patients across the United States. Located in San Diego, California, the company was founded by Rich Stoner, Dan Knudsen, and Kevin Cooksy in 2023. The company is backed by major private investors including Dimension Capital and Khosla Ventures.

Key Contact